X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
infectious diseases (11) 11
index medicus (10) 10
male (10) 10
adult (9) 9
female (9) 9
middle aged (9) 9
hiv infections - drug therapy (8) 8
hepatitis c - drug therapy (7) 7
immunology (7) 7
hepatitis c (6) 6
hepatitis c - complications (6) 6
hiv infections - complications (6) 6
human immunodeficiency virus--hiv (6) 6
dosage and administration (5) 5
hepatitis (5) 5
hiv (5) 5
patients (5) 5
therapy (5) 5
aged (4) 4
aids/hiv (4) 4
alpha-2a plus ribavirin (4) 4
anti-hiv agents - therapeutic use (4) 4
antiviral agents - administration & dosage (4) 4
article (4) 4
care and treatment (4) 4
cd4 lymphocyte count (4) 4
decision making (4) 4
drug therapy (4) 4
drug therapy, combination (4) 4
hcv (4) 4
hiv infection (4) 4
hiv infections - virology (4) 4
infected patients (4) 4
medical treatment (4) 4
research (4) 4
ribavirin (4) 4
risk factors (4) 4
treatment outcome (4) 4
analysis (3) 3
antiretroviral therapy (3) 3
clinical trials (3) 3
drugs (3) 3
human-immunodeficiency-virus (3) 3
primary care (3) 3
public, environmental & occupational health (3) 3
ritonavir (3) 3
virus diseases (3) 3
young adult (3) 3
abridged index medicus (2) 2
abt-450/r-ombitasvir (2) 2
adherence (2) 2
adolescent (2) 2
aids (2) 2
anti-hiv agents - administration & dosage (2) 2
anti-hiv agents - adverse effects (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy, highly active (2) 2
antiviral agents - therapeutic use (2) 2
atazanavir sulfate (2) 2
barriers (2) 2
co-infection (2) 2
coinfection (2) 2
coinfection - drug therapy (2) 2
complications and side effects (2) 2
cross-sectional studies (2) 2
dose-response relationship, drug (2) 2
double-blind (2) 2
efficacy (2) 2
genotype (2) 2
hepacivirus - genetics (2) 2
hiv infections - immunology (2) 2
hiv patients (2) 2
hiv-1 - drug effects (2) 2
hiv-1 - isolation & purification (2) 2
injection-drug users (2) 2
liver diseases (2) 2
los angeles (2) 2
management (2) 2
medicine, general & internal (2) 2
microbiology (2) 2
oligopeptides - therapeutic use (2) 2
patient compliance (2) 2
patient outcomes (2) 2
pilot projects (2) 2
practice patterns, physicians (2) 2
prognosis (2) 2
psychiatric-illness (2) 2
pyridines - pharmacology (2) 2
pyridines - therapeutic use (2) 2
research article (2) 2
ribavirin - administration & dosage (2) 2
ribavirin - adverse effects (2) 2
sulfonamides - administration & dosage (2) 2
sulfonamides - therapeutic use (2) 2
treatment eligibility (2) 2
treatment failure (2) 2
up-regulation (2) 2
uracil - analogs & derivatives (2) 2
urban-population (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, pp. 1223 - 1231
Journal Article
Infectious Diseases in Clinical Practice, ISSN 1056-9103, 07/2011, Volume 19, Issue 4, pp. 268 - 272
BACKGROUND:Women with human immunodeficiency virus (HIV) are now living longer, and few publications have addressed the long-term clinical safety and efficacy... 
nonnucleoside reverse transcriptase inhibitors | long-term | women
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96187
Simplification of antiretroviral therapy in patients with suppressed viremia may minimize long-term adverse effects. The study's primary objective was to... 
Anti-HIV Agents - pharmacology | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | Oligopeptides - adverse effects | Oligopeptides - therapeutic use | Lamivudine - adverse effects | Young Adult | Pyridines - adverse effects | Lipids - blood | Lamivudine - therapeutic use | Atazanavir Sulfate | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - adverse effects | Dideoxynucleosides - therapeutic use | Pyridines - therapeutic use | HIV Infections - blood | Dideoxynucleosides - pharmacology | Anti-HIV Agents - adverse effects | Treatment Outcome | Biomarkers - blood | HIV Infections - drug therapy | Aged | Lamivudine - pharmacology | Pyridines - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Drug Combinations | Simplification | Viremia | Ritonavir | Coagulation | Clinical trials | Lipids | Tenofovir | Hepatitis | Randomization | Hyperbilirubinemia | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Quality | Human immunodeficiency virus--HIV | All terrain vehicles | Drug dosages | Lipoproteins (high density) | Emtricitabine | Antiretroviral drugs | Kidneys | Abnormalities | Lamivudine | Inflammation | Ribonucleic acid--RNA | Patients | Cholesterol | Antiretroviral therapy | Protease inhibitors | Abacavir | Biomarkers | Adults | Kidney transplantation | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 02/2017, Volume 215, Issue 4, pp. 599 - 605
Journal Article
HIV Clinical Trials, ISSN 1528-4336, 06/2012, Volume 13, Issue 3, pp. 142 - 152
Journal Article
by Orrell, Catherine and Hagins, Debbie P and Belonosova, Elena and Porteiro, Norma and Walmsley, Sharon and Falcó, Vicenç and Man, Choy Y and Aylott, Alicia and Buchanan, Ann M and Wynne, Brian and Vavro, Cindy and Aboud, Michael and Smith, Kimberly Y and Cahn, Pedro Enrique and Cassetti, Lidia Isabel and Porteiro Barreira, Norma and Angel, Jonathan Benjamin and de Pokomandy, Alexandra and Harris, Marianne and Rachlis, Anita R and Walmsley, Sharon L and Allavena, Clotilde and Bouchaud, Oliver and Gatey, Caroline and Rami, Agathe and Casari, Salvatore and Di Perri, Giovanni and Lazzarin, Adriano and Maggiolo, Franco and Penco, Giovanni and Quirino, Tiziana and Rizzardini, Giuliano and Andrade-Villanueva, Jaime-Federico and Sierra-Madero, Juan G and Branco, Teresa and Serrao, Rosario and Teofilo, Eugenio JR and Melendez-Rivera, Ivan and Santiago, Lizette and Zorrilla, Carmen D and Belonosova, Elena and Chernova, Oksana E and Pokrovsky, Vadim and Rakhmanova, Aza Gasanovna and Tsybakova, Olga and Voronin, Eugene and Orrell, Catherine and Vally, Tasneem and Farisani, Livhuwani ML and Sebopa, Boitumelo Lucrecia and Barros, Carlos Aguado and Cano Sánchez, Alfredo and Castaño, Manuel and Falcó Ferrer, Vicens and González García, Juan J and Hernandez-Quero, Jose and Negredo Puigmal, Eugenia and Pérez Elías, María Jesús and Podzamczer Palter, Daniel and Portilla, Joaquin Sogorb and Viciana Fernández, Pompeyo and Manosuthi, Weerawat and Ruxrungtham, Kiat and Dockrell, David H and Hay, Phillip E and Johnson, Margaret A and Mackie, Nicola E and Orkin, Chloe M and Taylor, Steve and Bhatti, Laveeza and Brar, Indira and Brennan, Robert Owen and Cade, Jerry L and Casanas, Beata and Casey, Kathleen and Cunningham, Douglas and DeJesus, Edwin and Dietz, Craig and Dretler, Robin Henry and Eron, Joseph J and Felizarta, Franco Antoni B and Fife, Kenneth H and Hagins, Debbie P and Hoffman-Terry, Margaret and Jain, Mamta and Johnson, Marc Alexander and Kinder, Clifford A and Kumar, Princy N and Lewis, Stanley T and McDonald, Cheryl Kay and Meza, Armando D and Mounzer, Karam C and Newman, Cheryl L and Osiyemi, Olayemi O and Poblete, Ronald and Presti, Rachel M and Ramgopal, Moti and Rosenstock, Joel and Samuel, Rafik and Sandkovsky, Uriel Sebastian and ... and ARIA study team and ARIA Study Team
The Lancet HIV, ISSN 2352-3018, 12/2017, Volume 4, Issue 12, pp. e536 - e546
Dolutegravir is a once-daily integrase strand transfer inhibitor with no need for pharmacokinetic boosting that is approved for the treatment of HIV-1... 
INFECTIOUS DISEASES | INTEGRASE-INHIBITOR | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | DOUBLE-BLIND | SPRING-2 | EXPERIENCED PATIENTS | IMMUNOLOGY | ANTIRETROVIRAL-NAIVE ADULTS
Journal Article
AIDS Research and Treatment, ISSN 2090-1240, 2011, Volume 2011, pp. 903480 - 7
Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the... 
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 8/2008, Volume 28, Issue 3, pp. 289 - 293
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 04/2015, Volume 18, Issue 3 Suppl 2, pp. 20177 - n/a
Journal Article
Journal of the International Association of Physicians in AIDS Care, ISSN 1545-1097, 12/2012, Volume 11, Issue 6, pp. 369 - 373
Nevirapine (NVP) was the first nonnucleoside reverse transcriptase inhibitor (NNRTI) approved by the US Food and Drug Administration (FDA) in 1996, for the... 
Drugs | Antiretroviral drugs | Clinical trials | Treatment methods | FDA approval | Patients | Risk factors
Journal Article